A novel messenger RNA signature as a prognostic biomarker for predicting relapse in pancreatic ductal adenocarcinoma.

Oncotarget · 2017 · PMC5762289 · PMID 29340021

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

did not reach statistical significancep = 0.09so close (0.05 < p ≤ 0.1)

High-risk group might potentially benefit from TMT, although the p value did not reach statistical significance (HR = 0.48, 95% CI: 0.20–1.14, p = 0.09, Supplementary Figure 3D ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.